Aurobindo Pharma Limited, of Telangana, India recalls
2 recalls recorded since 2018, most recently on 16 June 2022. Status and classification are as published by the CPSC.
Recalls2
Ongoing (FDA)0
Terminated or completed0
Class I (FDA)0
Announced Consumer products
- Recall started
- 16 June 2022
- Reason
- The recalled over-the-counter product contains the regulated substance acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
- Remedy
- Consumers should immediately store the recalled product in a safe location out of reach and sight of children. Contact Kroger for information on how to properly dispose of the product and receive a full refund.
- Recall number
- 22164
- Kroger Arthritis Pain Acetaminophen, 225 count bottles
CPSC recall notice
Announced Consumer products
- Recall started
- 16 June 2022
- Reason
- The recalled over-the-counter products contain the regulated substance acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
- Remedy
- Consumers should immediately store the recalled products in a safe location out of reach and sight of children. Contact Aurohealth for information on how to return the product at your nearest Walgreens store to receive a full refund.
- Recall number
- 22161
- Walgreens Pain Reliever Acetaminophen, 150 count bottles
CPSC recall notice
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.